Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, on what basis the Pharmaceutical Price Regulation Scheme rebate allocation has been calculated for Scotland.

Companies pay all Pharmaceutical Price Regulation Scheme payments to the Department of Health in England. The total United Kingdom payments will be allocated to each of the four UK countries in a fair way and the estimated payments for England have been included within the NHS England budget. The method for apportioning 2014-15 payments will be based on primary care data for spend on licensed branded medicines, as the most consistent data set available across the UK. Income will be apportioned using prescribing data for the same period as the income relates, on a quarterly basis.